Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
US9295687B1 · kind B1 · utility
3Cited by
10References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2015 |
| Grant date | Mar 29, 2016 |
| Priority date | — |
| Expiry date | Jul 10, 2035 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB65D81/2069
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to high purity cangrelor, pharmaceutical formulations comprising high purity cangrelor as an active ingredient, methods for preparing such compounds and formulations, and methods for using the pharmaceutical formulations in the inhibition of platelet activation and aggregation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.